Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo

  • J. S. Kim
  • , S. Y. Oh*
  • , S. H. Lee
  • , J. H. Kang
  • , D. U. Kim
  • , S. H. Jeong
  • , K. D. Choi
  • , I. S. Moon
  • , B. K. Kim
  • , H. J. Oh
  • , H. J. Kim
  • *Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

Abstract

Objective: To determine the immediate and long-term therapeutic efficacies of Gufoni and head-shaking maneuvers in apogeotropic type of benign paroxysmal positional vertigo involving the horizontal semicircular canal (HC-BPPV), a randomized, prospective, sham-controlled study was conducted. Methods: In 10 nationwide dizziness clinics in Korea, 157 consecutive patients (95 women, age range: 18-89 years, mean age ± SD = 59.9 ± 13.6) with apogeotropic HC-BPPV were randomized to Gufoni (n = 52), head-shaking (n = 54), or sham maneuver (n = 51). For Gufoni maneuver, patients underwent ipsilesional side-lying and upward head-turn for migration of the debris toward the vestibule. Immediate responses were determined within 1 hour after a maximum of 2 trials of each maneuver and in the following day. The patients also had weekly follow-ups for 1 month after the initial maneuver. Results: After a maximum of 2 maneuvers on the initial visit day, Gufoni (38/52, 73.1%) and head-shaking (33/53, 62.3%) maneuvers showed better responses than the sham maneuver (17/49, 34.7%). The cumulative therapeutic effects were also better with Gufoni (p < 0.001) and head-shaking (p = 0.026) maneuvers compared with the sham maneuver. However, therapeutic efficacies did not differ between the Gufoni and head-shaking groups in terms of both immediate (p = 0.129) and long-term (p = 0.239) outcomes. Conclusion: Using a prospective randomized trial, we demonstrated that the Gufoni and headshaking maneuvers are effective in treating apogeotropic HC-BPPV. Classification of evidence: This study provides Class II evidence that Gufoni and head-shaking maneuvers are effective in treating apogeotropic horizontal BPPV up to 1 month after initial treatment. Clinical trial registration: NCT00810641.

Original languageEnglish
Pages (from-to)159-166
Number of pages8
JournalNeurology
Volume78
Issue number3
DOIs
StatePublished - 2012.01.17

Quacquarelli Symonds(QS) Subject Topics

  • Medicine

Fingerprint

Dive into the research topics of 'Randomized clinical trial for apogeotropic horizontal canal benign paroxysmal positional vertigo'. Together they form a unique fingerprint.

Cite this